Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coated Aldehyde Oxystarch for Reducing Protein-Bound Uremic Toxins in ESRD
NCT07653711Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Apr 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial of aldehyde oxystarch in end stage renal disease (ESRD), sponsored by Peking University People's Hospital. Primary endpoints: Absolute Change From Baseline in Serum Indoxyl Sulfate Level at 3 months and Percentage Change From Baseline in Serum Indoxyl Sulfate Level at 3 months. Started Apr 2025; status: recruiting.
02
Drugs
aldehyde oxystarch
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT07653711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07653711.